Dr. Elizabeth Shpall, MD

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Cincinnati / Main Campus

  Medical School, 1980

• Noninvasive Bioluminescent Imaging Demonstrates Long-Term Multilineage Engraftment of Ex Vivo-Expanded CD34-Selected Umbilical Cord Blood Cells, 2012-05-02

• Haploidentical NK cells infused prior to allogeneic stem cell transplant for myeloid malignancies: a phase I trial, 2016-04-16

• Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies, 2022-11-10

• Bone marrow stromal cells induce an ALDH+stem cell-like phenotype and enhance therapy resistance in AML through a TGF-ß-p38-ALDH2 pathway, 2020-11-30

• HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant, 2019-01-23

• Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD, 2021-05-04

• Role of MSC-derived Galectin 3 in the AML Microenvironment, 2018-04-12

• Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy, 2018-08-06

• Novel Techniques forEx VivoExpansion of Cord Blood: Clinical Trials, 2015-12-11

• Failure is not fatal: Long-term remission in refractory acute myeloid leukemia (AML) after graft failure of cord blood stem cells., 2010-01-07

• Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit ‘ALL', 2018-02-13

• Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy, 2022-10-13

• Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis, 2015-11-10

• Impact Of t(11;14)(q13;q32) On The Outcome Of Autologous Hematopoietic Cell Transplantation In Multiple Myeloma, 2013-05-31

• SIRPa Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies, 2022-07-07

• Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2, 2021-02-04

• Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC, 2012-12-19

• Similar Transplant Outcomes for AML/MDS Patients with Haploidentical versus 10/10 HLA Matched Unrelated and Related Donors, 2014-09-28

• Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B cell function and inhibition of the PD-1/PD-L1 pathway, 2017-10-03

• Fludarabine with Myeloablative Timed-Sequential Busulfan in Older Patients: Results of a Randomized Phase II Clinical Trial, 2018-11-01

• Decrease post-transplant relapse using donor-derived expanded NK-cells, 2021-07-26

• Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas, 2015-06-11

• Relapse Risk and Survival in Patients with FLT3 Acute Myeloid Leukemia Undergoing Stem Cell Transplantation, 2017-02-13

• Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation Following Reduced Intensity Conditioning Regimens Improves Time to Neutrophil Recovery, 2017-05-12

• Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment, 2022-11-16

• Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application, 2016-02-23

• Reversible Ureteral Obstruction due to Polyomavirus Infection after Precutaneous Nephrostomy Catheter Placement, 2011-03-09

• Double Epigenetic Modulation of High-Dose Chemotherapy With Azacitidine and Vorinostat for Patients With Refractory or Poor-Risk Relapsed Lymphoma, 2016-05-20

• Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation, 2016-03-07

• Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia, 2016-02-26

• Fludarabine with pharmacokinetically-guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients, 2016-12-19

• KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape, 2022-09-29

• Impact of Conditioning Chemotherapy on Lymphocyte Kinetics and Outcomes in LBCL Patients Treated with CAR T-cell Therapy, 2022-09-20

• Impact of Donor Type and Melphalan Dose on Allogeneic Transplant Outcomes for Patients with Lymphoma, 2019-02-11

• Allogeneic Hematopoietic Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), 2021-10-11

• Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation, 2015-03-31

• Allogeneic Transplantation in First Remission Improves Outcome Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD positive AML, 2016-04-04

• Cord Blood as a Source of Natural Killer Cells, 2016-01-05

• Mucus-degrading Bacteroides link carbapenems to aggravated graft-versushost disease, 2022-09-29

• CD4-/CD8-Variant of T-Cell Large Granular Lymphocytic Leukemia or Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Dilemma, 2013-06-22

• Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular Therapy, 2018-12-18

• Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem-cell Transplant Outcomes, 2017-08-24

• GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells, 2021-02-26

• Pentostatin Therapy for Steroid-Refractory Acute Graft Versus Host Disease: Identifying Those Who May Benefit, 2017-12-21

• RapidEx VivoExpansion of Highly Enriched Human Invariant Natural Killer T Cells via Single Antigenic Stimulation for Cell Therapy to Prevent Graft Versus Host Disease., 2018-07-31

• Haploidentical vs Matched Unrelated vs Matched Sibling Donor HCT with Post-Transplantation Cyclophosphamide, 2022-05-02

• Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia, 2022-09-20

• Results of a 2-Arm, Phase 2 Clinical Trial Using Post-Transplantation Cyclophosphamide for the Prevention of Graft-Versus-Host Disease in Haploidentical Donor and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation, 2016-07-12

• Chimeric antigen receptor T-cell therapy - assessment and management of toxicities, 2017-09-19

• Utility of the Enzyme-Linked Immunospot Interferon-?-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients, 2016-02-11

• A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept, 2023-06-01

• Cord Blood Graft Engineering, 2012-10-17

• Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression Free Survival for Patients with Chronic Myelomonocytic Leukemia, 2015-09-04

• General and Virus-Specific Immune Cell Reconstitution Following Double Cord Blood Transplantation, 2015-02-20

• Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure, 2022-01-29

• The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide, 2018-01-15

• An improved patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses, 2019-06-11

• Prolonged survival with longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma, 2016-09-28

• High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients, 2021-04-28

• Bacteroides ovatusalleviates dysbiotic microbiota-induced intestinal graft-versus-host disease, 2023-01-31

• Fludarabine, Melphalan, Thiotepa and ATG Conditioning for Unrelated Cord Blood Transplantation, 2012-01-03

• Symptomatic BK Virus Infection Is Associated with Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients, 2016-03-02

• Fucosylation enhances activity of cytotoxic T lymphocytes against breast cancer, 2015-11-04

• PHASE II TRIAL OF HIGH-DOSE GEMCITABINE/BUSULFAN/MELPHALAN WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR PRIMARY REFRACTORY OR POOR-RISK RELAPSED HODGKIN'S LYMPHOMA, 2018-03-02

• Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells, 2012-04-23

• Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated cord blood-derived NK cells facilitates CAR-like responses against CD30+ malignancies, 2021-05-13

• Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-specific Cytotoxic T Lymphocytes, 2019-01-15